Samuel Sherratt

Elucida Research LLC
Beverly, Massachusetts

Samuel C.R. Sherratt, B.S., is the senior research scientist at Elucida Research in Beverly, Massachusetts, USA. Elucida Research is a biotechnology research firm that serves the health sciences community, specializing in cardiovascular drug research and lipid biochemistry and biophysics. Mr. Sherratt is also an industrial Ph.D. candidate in Biochemistry at the University of New Hampshire in Durham, New Hampshire. He has authored or co-authored more than 80 scientific publications including original articles, reviews, and abstracts.

Disclosure information not submitted.

Presentation(s):

• Eicosapentaenoic Acid Favorably Modulates Protein Expression in Pulmonary Endothelial Inflammation

  Monday, April 18, 2022
  7:00 AM – 8:00 AM US CST

• Eicosapentaenoic Acid Increases Endothelial Function and Heme Oxygenase-1 in Pulmonary Inflammation

  Monday, April 18, 2022
  7:00 AM – 8:00 AM US CST

• Eicosapentaenoic Acid Reduces Pulmonary Endothelial Cell Adhesion Protein Expression With IL-6

  Monday, April 18, 2022
  7:00 AM – 8:00 AM US CST